2024-03-28T18:19:27Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_7F8DDEE8DA1E
2024-03-23T02:36:15Z
serval:BIB_7F8DDEE8DA1E
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance.
10.1038/s41571-019-0218-0
000482189100013
31092901
Martins
F.
author
Sofiya
L.
author
Sykiotis
G.P.
author
Lamine
F.
author
Maillard
M.
author
Fraga
M.
author
Shabafrouz
K.
author
Ribi
C.
author
Cairoli
A.
author
Guex-Crosier
Y.
author
Kuntzer
T.
author
Michielin
O.
author
Peters
S.
author
Coukos
G.
author
Spertini
F.
author
Thompson
J.A.
author
Obeid
M.
author
article
review
2019-09
Nature reviews. Clinical oncology
1759-4782
1759-4774
journal
16
9
563-580
Antineoplastic Agents, Immunological/adverse effects
Drug-Related Side Effects and Adverse Reactions/diagnosis
Drug-Related Side Effects and Adverse Reactions/epidemiology
Drug-Related Side Effects and Adverse Reactions/therapy
Humans
Immunologic Factors/adverse effects
Immunotherapy/adverse effects
Immunotherapy/methods
Neoplasms/drug therapy
eng
60_published
peer-reviewed
Publication types: Journal Article ; Research Support, Non-U.S. Gov't ; Review
Publication Status: ppublish